Figure 1:
Incidence rates of venous thromboembolism events (deep vein thrombosis, pulmonary embolism, deep vein thrombosis/pulmonary embolism) before and after initiation of immune checkpoint inhibitors (entire cohort n=2854)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.